Tag Archive for: financing

Sofinnova Partners exceeds target with €165M biotech acceleration fund, Europe’s largest, with strong Pharma support

/in

Biovelocita II attracts robust support from leading pharmaceutical companies, including Amgen, Bristol Myers Squibb, and Pfizer Ventures The fund has already screened over 300 projects and made several investments into new companies to catalyze transformative innovation in biotechnology PARIS, France – March 18, 2025 – Sofinnova Partners (“Sofinnova”), a leading European life sciences venture capital […]

Read more

Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty

/in

HealthCare Royalty and Heidelberg Pharma amend royalty financing agreement to provide for USD 20 million payment Heidelberg Pharma extends cash runway into 2027 Ladenburg, Germany, 13 March 2025 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech Company developing innovative Antibody Drug Conjugates (ADCs), and HealthCare Royalty (HCRx) today announced that they have signed […]

Read more

Sofinnova Partners raises €1.2 billion to fuel the next wave of life sciences innovation

/in

Leading European venture capital firm exceeds €4 billion in assets under management, doubling its AUM in the last five years PARIS, France – March 4, 2025 — Sofinnova Partners (“Sofinnova”), a leading European venture capital firm in life sciences based in Paris, London, and Milan, today announced it had raised €1.2 billion across its platform […]

Read more

Commit Biologics announces €5.5m seed financing extension investment by Korys to further develop its Bispecific Complement Engaging (BiCE™) platform

/in

Additional funding from new investor Korys, joining existing syndicate members Novo Holdings and Bioqube Ventures, brings total seed financing to €21.5m Funds will be used to further develop Commit’s BiCE platform and move towards drug candidate (DC) selection Eva Van Overmeire, Senior Investment Manager at Korys, also joins Commit’s Board of Directors Mikkel Wandahl Pedersen […]

Read more

Hot topic: JPM shines bright amid the January gloom

/in

2025 has already begun with drama in the U.S., as Los Angeles recovers from deadly wildfires and Donald Trump is sworn in for his second presidency. And so it was that the mood going into the annual JP Morgan Healthcare Conference was clouded by uncertainty. With its timing in January, JPM is often seen as […]

Read more